HEALTH● LOWJul 8 · Jul 8, 2026, 1:52 PM
Immunome granted FDA review for tumor candidate
Seeking Alpha Tech
Immunome has received FDA review for a tumor candidate, indicating a step forward in its development. This signifies regulatory progress for a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoWhy the world’s first spinal cord transplant is so controversialNew ScientistHEALTH31m agoFG disburses N249.6bn health fund in three years, targets 17,600 facilitiesPremium TimesHEALTH1h agoChristina Applegate left with health questions after revealing MS misdiagnosisCBS NewsHEALTH1h agoLagos begins mandatory health insurance enforcement January 2027Vanguard Nigeria